In the company’s news yesterday,
BioDelivery Sciences International, Inc. announced that Niraj Vasisht, Ph.D. has been promoted to senior vice president of product development and chief technical officer.
“Dr. Vasisht has made an enormous contribution to the development of BDSI’s lead product, ONSOLIS, from the laboratory through clinical testing and regulatory review in the U.S. and Europe,” said Andrew Finn, executive vice president of product development. “Dr. Vasisht’s pharmaceutical development experience, capability and leadership are allowing BDSI to emerge as a leader in the use of drug delivery technologies to enhance pharmaceuticals for the benefits of patients.”
Dr. Vasisht is an internationally recognized expert in the field of microencapsulation and nanoencapsulation. He joined BDSI in 2005 as vice president of product development, and has been responsible for the development, manufacture and supply chain management of the company’s BioErodible MucoAdhesive (BEMA) and the pain treatment drug ONSOLIS, scheduled to be launched next year.
Chief Technical Officer is a newly created position within the company. In that capacity, Dr. Vasisht will help lead BDSI’s technical efforts in product formulation, development and manufacturing.
“The promotion of Dr. Vasisht to this role is an important step in BDSI’s plans to expand its portfolio of products using the BEMA drug delivery technology and to evaluate other applications, processes and technologies of interest,” said Finn, Pharm.D.
About QualityStocks
QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. QualityStocks is dedicated to assisting emerging public companies with their advertising efforts and now has over 500,000+ subscribers that receive The Daily Stock Newsletters.
To sign up for “The QualityStocks Daily Newsletter” please visit http://www.qualitystocks.net/
Please see disclaimer on QualityStocks website: http://Disclaimer.QualityStocks.net
Forward-Looking Statement:
This release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. Risks and uncertainties applicable to the company and its business could cause the company's actual results to differ materially from those indicated in any forward-looking statements.
